Liu Meichen, Li Kai, Wang Yunyun, Zhao Guoqing, Jiang Jinlan
Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, China.
Department of Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, China.
Stem Cells Int. 2020 Dec 28;2020:8861251. doi: 10.1155/2020/8861251. eCollection 2020.
Neuropathic pain (NP) is pain caused by somatosensory nervous system injury or disease. Its prominent symptoms are spontaneous pain, hyperalgesia, and allodynia, and the sense of pain is extremely strong. Owing to the complex mechanism, conventional painkillers lack effectiveness. Recently, research on the treatment of NP by stem cells is increasing and promising results have been achieved in preclinical research. In this review, we briefly introduce the neuropathic pain, the current treatment strategy, and the development of stem cell therapy, and we collected the experimental and clinical trial articles of many kinds of stem cells in the treatment of neuropathic pain from the past ten years. We analyzed and summarized the general efficacy and mechanism of stem cells in the treatment of neuropathic pain. We found that the multiple-mechanism approach was different from the single mechanism of routine clinical drugs; stem cells play a role in peripheral mechanism, central mechanism, and disinhibition of spinal cord level that lead to neuropathic pain, so they are more effective in analgesia and treatment of neuropathic pain.
神经性疼痛(NP)是由躯体感觉神经系统损伤或疾病引起的疼痛。其突出症状为自发性疼痛、痛觉过敏和感觉异常,且疼痛感极强。由于发病机制复杂,传统止痛药效果欠佳。近年来,干细胞治疗NP的研究日益增多,并在临床前研究中取得了有前景的成果。在本综述中,我们简要介绍了神经性疼痛、当前的治疗策略以及干细胞治疗的进展,并收集了过去十年中多种干细胞治疗神经性疼痛的实验和临床试验文章。我们分析并总结了干细胞治疗神经性疼痛的总体疗效和机制。我们发现,多机制方法不同于常规临床药物的单一机制;干细胞在外周机制、中枢机制以及导致神经性疼痛的脊髓水平去抑制方面发挥作用,因此在镇痛和治疗神经性疼痛方面更有效。